- Home
- IPHA vs GAUZ Comparison
IPHA vs GAUZ Comparison
Compare IPHA & GAUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- GAUZ
- Stock Information
- Founded
- IPHA 1999
- GAUZ 2009
- Country
- IPHA France
- GAUZ Israel
- Employees
- IPHA N/A
- GAUZ N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- GAUZ Industrial Machinery/Components
- Sector
- IPHA Health Care
- GAUZ Miscellaneous
- Exchange
- IPHA Nasdaq
- GAUZ Nasdaq
- Market Cap
- IPHA 160.1M
- GAUZ 180.1M
- IPO Year
- IPHA 2019
- GAUZ 2024
- Fundamental
- Price
- IPHA $1.83
- GAUZ $8.60
- Analyst Decision
- IPHA Strong Buy
- GAUZ Strong Buy
- Analyst Count
- IPHA 1
- GAUZ 4
- Target Price
- IPHA $11.00
- GAUZ $15.50
- AVG Volume (30 Days)
- IPHA 10.0K
- GAUZ 23.9K
- Earning Date
- IPHA 03-27-2025
- GAUZ 08-07-2025
- Dividend Yield
- IPHA N/A
- GAUZ N/A
- EPS Growth
- IPHA N/A
- GAUZ N/A
- EPS
- IPHA N/A
- GAUZ N/A
- Revenue
- IPHA $20,831,349.00
- GAUZ $101,165,000.00
- Revenue This Year
- IPHA $209.83
- GAUZ $28.49
- Revenue Next Year
- IPHA $83.15
- GAUZ $47.77
- P/E Ratio
- IPHA N/A
- GAUZ N/A
- Revenue Growth
- IPHA N/A
- GAUZ 18.63
- 52 Week Low
- IPHA $1.29
- GAUZ $6.78
- 52 Week High
- IPHA $3.51
- GAUZ $14.44
- Technical
- Relative Strength Index (RSI)
- IPHA 33.33
- GAUZ N/A
- Support Level
- IPHA $1.82
- GAUZ N/A
- Resistance Level
- IPHA $2.21
- GAUZ N/A
- Average True Range (ATR)
- IPHA 0.07
- GAUZ 0.00
- MACD
- IPHA -0.03
- GAUZ 0.00
- Stochastic Oscillator
- IPHA 6.74
- GAUZ 0.00
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.